08:00 , Dec 20, 2012 |  BC Innovations  |  Distillery Therapeutics

Indication: Cardiovascular disease

This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Cardiovascular disease Myocardial infarction (MI); ischemia/reperfusion injury MicroRNA-199a-3p (miR-199a-3p); miR-590-3p Rodent studies suggest exogenous human miR-590-3p and miR-199a-3p could help promote cardiac...